SRx Health Solutions (SRXH) Company Report

Analyst Coverage

Research analysts covering SRx Health Solutions.

Recent press releases and 8-K filings for SRXH.

SRx Health Solutions Regains Compliance with NYSE Listing Standards

SRXH

Delisting/Listing Issues

SRx Health Solutions, Inc. (SRXH) announced on January 8, 2026, that the NYSE American accepted its plan to regain compliance with Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.
The company was previously notified on October 14, 2025, that it had fallen below the NYSE's continued listing standard, which requires stockholders' equity of $4 million or more if the company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years.
As of June 30, 2025, SRXH reported stockholders' equity of ($45.9) million, and had losses from continuing operations and/or net losses in three out of its four most recent fiscal years ended December 31, 2024.
The company's listing is being continued pursuant to an extension with a targeted completion date of July 14, 2026, during which SRXH will provide quarterly updates to the NYSE American.

Jan 8, 2026, 4:54 PM

SRx Health Solutions to Acquire EMJ Crypto Technologies

SRXH

M&A

CEO Change

Executive Compensation

SRx Health Solutions, Inc. (SRXH) has entered into a definitive agreement to acquire EMJ Crypto Technologies (EMJX), a digital-asset treasury platform, for approximately $55 million in an all-stock transaction.
Upon closing, expected in the first quarter of 2026, Eric M. Jackson, EMJX's Founder and CEO, is anticipated to become the Chief Executive Officer and Chairman of the combined company.
The acquisition aims to establish a next-generation digital asset treasury operating system and platform, leveraging EMJX's quantitative models and AI-enabled risk systems for multi-asset digital treasury management.
The transaction is subject to customary closing conditions, including SRx Health stockholder approval.
The combined company expects to operate under the EMJX name and intends to pursue a ticker symbol change.

Dec 16, 2025, 1:47 PM

SRx Health Solutions to Issue Convertible Preferred Stock and Address Financial Controls

SRXH

Convertible Preferred Issuance

Financial Restatement

SRx Health Solutions, Inc. (SRXH) reported on October 27, 2025, the creation of 75,000 shares of Series A Convertible Preferred Stock by its Board of Directors on October 20, 2025.
These Series A Preferred Shares are convertible into Common Stock at a fixed price of $0.6109, with provisions for an alternate conversion price upon specific triggering events.
The company intends to seek stockholder approval to increase its authorized shares of Common Stock from 200,000,000 to 5,000,000,000 to facilitate the conversion of these Preferred Shares and Warrants.
An independent auditor identified material weaknesses in internal control over financial reporting for SRx Health Solutions (Canada) Inc. for the fiscal year ended September 30, 2024, and the company recorded a $1.8 million reduction to accumulated deficit as of September 30, 2024, due to a revenue error related to discontinued operations.

Oct 31, 2025, 9:20 PM

SRx Health Solutions Stockholders Approve Key Corporate Actions

SRXH

Proxy Vote Outcomes

Capital Structure Change

On October 8, 2025, SRx Health Solutions, Inc. stockholders approved the issuance of common stock or convertible securities exceeding 19.99% of outstanding common stock under existing agreements and for a proposed future offering.
Stockholders also approved an amendment to the Certificate of Incorporation to increase the authorized common stock from 200,000,000 to 5,000,000,000 shares.
An additional reverse stock split was authorized, with a ratio between 15-to-1 and 85-to-1, to be implemented by March 31, 2026.
The quorum required for stockholder meetings was reduced from a majority to one-third of outstanding common stock.